Status: current, Defined. Date: 31-May 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4128041000168118 | Nesina Met 12.5 mg/500 mg (alogliptin 12.5 mg + metformin hydrochloride 500 mg) tablet, 200 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4128051000168116 | Nesina Met 12.5 mg/500 mg tablet, 200 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nesina Met 12.5 mg/500 mg tablet, 200 | Is a | alogliptin 12.5 mg + metformin hydrochloride 500 mg tablet, 200 | true | Inferred relationship | Some | ||
| Nesina Met 12.5 mg/500 mg tablet, 200 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Nesina Met 12.5 mg/500 mg tablet, 200 | has TPUU | Nesina Met 12.5 mg/500 mg tablet | true | Inferred relationship | Some | 1 | |
| Nesina Met 12.5 mg/500 mg tablet, 200 | has TP | Nesina Met 12.5 mg/500 mg | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nesina Met 12.5 mg/500 mg tablet, 200, blister pack | Is a | True | Nesina Met 12.5 mg/500 mg tablet, 200 | Inferred relationship | Some |
Reference Sets
Unit of use quantity reference set
Description inactivation indicator reference set
Trade product pack reference set
FHIR